# Ghrelin Regulation and Structure: Effect of Thiazolidinedione Therapy on Ghrelin

> **NCT00843791** · NA · TERMINATED · sponsor: **Oregon Health and Science University** · enrollment: 6 (actual)

## Conditions studied

- Obesity
- Insulin Resistance

## Interventions

- **DRUG:** placebo
- **DRUG:** pioglitazone

## Key facts

- **NCT ID:** NCT00843791
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Insufficient funds to continue.
- **Last updated:** 2023-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00843791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00843791, "Ghrelin Regulation and Structure: Effect of Thiazolidinedione Therapy on Ghrelin". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00843791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*